| __timestamp | Xenon Pharmaceuticals Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 11768000 | 396000000 |
| Thursday, January 1, 2015 | 15152000 | 364000000 |
| Friday, January 1, 2016 | 19828000 | 376000000 |
| Sunday, January 1, 2017 | 25573000 | 382000000 |
| Monday, January 1, 2018 | 23634000 | 432000000 |
| Tuesday, January 1, 2019 | 38845000 | 457000000 |
| Wednesday, January 1, 2020 | 50523000 | 463000000 |
| Friday, January 1, 2021 | 75463000 | 508000000 |
| Saturday, January 1, 2022 | 105767000 | 539000000 |
| Sunday, January 1, 2023 | 167512000 | 614000000 |
| Monday, January 1, 2024 | 686000000 |
In pursuit of knowledge
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Zoetis Inc. and Xenon Pharmaceuticals Inc. have demonstrated contrasting yet fascinating trajectories in their R&D investments.
Zoetis Inc., a leader in animal health, has consistently increased its R&D spending, growing by approximately 55% from 2014 to 2023. This steady climb underscores Zoetis's commitment to innovation, ensuring they remain at the forefront of veterinary medicine.
In contrast, Xenon Pharmaceuticals Inc. has experienced a dramatic surge in R&D expenses, skyrocketing by over 1,300% during the same period. This rapid increase highlights Xenon's aggressive pursuit of breakthroughs in neurological therapies.
Both companies exemplify the dynamic nature of pharmaceutical R&D, each carving its path to future success.
Zoetis Inc. or Genmab A/S: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Zoetis Inc. and Viatris Inc.
Research and Development Investment: Zoetis Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs MorphoSys AG
Research and Development: Comparing Key Metrics for Zoetis Inc. and BioCryst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Xenon Pharmaceuticals Inc.
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: BeiGene, Ltd. vs Xenon Pharmaceuticals Inc.
Viatris Inc. or Xenon Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Alpine Immune Sciences, Inc. vs Xenon Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for CRISPR Therapeutics AG and Xenon Pharmaceuticals Inc.